Clinical Trials

Syntara are global leaders in amine oxidase chemistry and biology with more than a decade of experience in this field. This has resulted in extensive collaborations with scientific and clinical thought leaders worldwide and multiple publications in high impact scientific journals.

Syntara’s drug pipeline includes drugs at discovery, pre clinical, clinical phase 1 and phase 2 stage. Syntara has active clinical programs in three therapeutic areas:

null

Cancer

null

Skin scarring

null

Neurodegenerative disease

Syntara’s Compassionate Use Policy

If you are not able to participate in a Syntara clinical trial, you may be eligible for compassionate access (also known as early access) to medicine. Please email us for more information about our Compassionate Use policy.

Email: medical.information@syntaratx.com.au

Syntara

Collaborating with scientific and clinical thought leaders worldwide and multiple publications in high-impact scientific journals.